Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Infection related hospitalizations after prostate biopsy in a statewide quality improvement collaborative.

Womble PR, Dixon MW, Linsell SM, Ye Z, Montie JE, Lane BR, Miller DC, Burks FN; Michigan Urological Surgery Improvement Collaborative.

J Urol. 2014 Jun;191(6):1787-92. doi: 10.1016/j.juro.2013.12.026. Epub 2013 Dec 15.

PMID:
24345442
2.

A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy.

Womble PR, Linsell SM, Gao Y, Ye Z, Montie JE, Gandhi TN, Lane BR, Burks FN, Miller DC; Michigan Urological Surgery Improvement Collaborative.

J Urol. 2015 Aug;194(2):403-9. doi: 10.1016/j.juro.2015.03.126. Epub 2015 Apr 17.

PMID:
25896556
3.

Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis.

Adibi M, Hornberger B, Bhat D, Raj G, Roehrborn CG, Lotan Y.

J Urol. 2013 Feb;189(2):535-40. doi: 10.1016/j.juro.2012.08.194. Epub 2012 Oct 8.

PMID:
22982426
4.

Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis.

Adibi M, Pearle MS, Lotan Y.

BJU Int. 2012 Jul;110(2 Pt 2):E86-91. doi: 10.1111/j.1464-410X.2011.10768.x. Epub 2011 Nov 24.

5.

Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.

Liss MA, Taylor SA, Batura D, Steensels D, Chayakulkeeree M, Soenens C, Rao GG, Dash A, Park S, Patel N, Woo J, McDonald M, Nseyo U, Banapour P, Unterberg S, Ahlering TE, Van Poppel H, Sakamoto K, Fierer J, Black PC.

J Urol. 2014 Dec;192(6):1673-8. doi: 10.1016/j.juro.2014.06.005. Epub 2014 Jun 10.

PMID:
24928266
6.

Reduction in hospital admissions with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies.

Luong B, Danforth T, Visnjevac O, Suraf M, Duff M, Chevli KK.

Urology. 2015 Mar;85(3):511-6. doi: 10.1016/j.urology.2014.10.047. Epub 2015 Jan 14.

PMID:
25596154
7.

Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care.

Taylor AK, Zembower TR, Nadler RB, Scheetz MH, Cashy JP, Bowen D, Murphy AB, Dielubanza E, Schaeffer AJ.

J Urol. 2012 Apr;187(4):1275-9. doi: 10.1016/j.juro.2011.11.115. Epub 2012 Feb 16.

PMID:
22341272
8.

Infection-related hospital admissions after transrectal biopsy of the prostate.

Sanders A, Buchan N.

ANZ J Surg. 2013 Apr;83(4):246-8. doi: 10.1111/ans.12073. Epub 2013 Jan 25.

PMID:
23346881
9.

The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?

Feliciano J, Teper E, Ferrandino M, Macchia RJ, Blank W, Grunberger I, Colon I.

J Urol. 2008 Mar;179(3):952-5; discussion 955. doi: 10.1016/j.juro.2007.10.071. Epub 2008 Jan 22.

PMID:
18207185
10.

Variation in prostate cancer detection rates in a statewide quality improvement collaborative.

Riedinger CB, Womble PR, Linsell SM, Ye Z, Montie JE, Miller DC, Lane BR; Michigan Urological Surgery Improvement Collaborative.

J Urol. 2014 Aug;192(2):373-8. doi: 10.1016/j.juro.2014.02.088. Epub 2014 Feb 25.

PMID:
24582538
11.

Antibiotic prophylaxis for transrectal prostate biopsy-a new strategy.

Antsupova V, Nørgaard N, Bisbjerg R, Nygaard Jensen J, Boel J, Jarløv JO, Arpi M.

J Antimicrob Chemother. 2014 Dec;69(12):3372-8. doi: 10.1093/jac/dku293. Epub 2014 Aug 11.

PMID:
25114164
12.

Infectious complications and hospital admissions after prostate biopsy in a European randomized trial.

Loeb S, van den Heuvel S, Zhu X, Bangma CH, Schröder FH, Roobol MJ.

Eur Urol. 2012 Jun;61(6):1110-4. doi: 10.1016/j.eururo.2011.12.058. Epub 2012 Jan 5.

PMID:
22244150
13.

The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance.

Ehdaie B, Vertosick E, Spaliviero M, Giallo-Uvino A, Taur Y, O'Sullivan M, Livingston J, Sogani P, Eastham J, Scardino P, Touijer K.

J Urol. 2014 Mar;191(3):660-4. doi: 10.1016/j.juro.2013.08.088. Epub 2013 Sep 7.

PMID:
24018237
14.

Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis.

Liss MA, Kim W, Moskowitz D, Szabo RJ.

J Urol. 2015 Aug;194(2):397-402. doi: 10.1016/j.juro.2015.03.110. Epub 2015 Apr 3.

PMID:
25846415
15.

Antibiotic prophylaxis for transrectal ultrasound biopsy of the prostate in Ireland.

Smyth LG, Mulvin DW.

Ir J Med Sci. 2012 Mar;181(1):33-5. doi: 10.1007/s11845-011-0774-5. Epub 2011 Nov 6.

PMID:
22057660
16.

Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study.

Wagenlehner FM, van Oostrum E, Tenke P, Tandogdu Z, Çek M, Grabe M, Wullt B, Pickard R, Naber KG, Pilatz A, Weidner W, Bjerklund-Johansen TE; GPIU investigators.

Eur Urol. 2013 Mar;63(3):521-7. doi: 10.1016/j.eururo.2012.06.003. Epub 2012 Jun 12.

PMID:
22704727
17.

Risk factors for infection following prostate biopsy - a case control study.

Anderson E, Leahy O, Cheng AC, Grummet J.

BMC Infect Dis. 2015 Dec 23;15:580. doi: 10.1186/s12879-015-1328-7.

18.

Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin.

Lee JK, Lee S, Hong SK, Byun SS, Lee SE.

BMC Urol. 2016 Aug 24;16(1):51. doi: 10.1186/s12894-016-0169-z.

19.

Emergency hospital admissions attributable to infective complications of prostate biopsy despite appropriate prophylaxis: need for additional infection prevention strategies?

Gopal Rao G, Batura D.

Int Urol Nephrol. 2014 Feb;46(2):309-15. doi: 10.1007/s11255-013-0529-5. Epub 2013 Aug 10.

PMID:
23934620
20.

Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?

Steensels D, Slabbaert K, De Wever L, Vermeersch P, Van Poppel H, Verhaegen J.

Clin Microbiol Infect. 2012 Jun;18(6):575-81. doi: 10.1111/j.1469-0691.2011.03638.x. Epub 2011 Sep 29.

Supplemental Content

Support Center